Autor: |
Jian-Bang Xu, Wei-Jie Guan, Yi-Lin Zhang, Zhuo-Er Qiu, Lei Chen, Xiao-Chun Hou, Junqing Yue, Yu-Yun Zhou, Jie Sheng, Lei Zhao, Yun-Xin Zhu, Jing Sun, Jincun Zhao, Wen-Liang Zhou, Nan-Shan Zhong |
Jazyk: |
angličtina |
Rok vydání: |
2024 |
Předmět: |
|
Zdroj: |
Signal Transduction and Targeted Therapy, Vol 9, Iss 1, Pp 1-15 (2024) |
Druh dokumentu: |
article |
ISSN: |
2059-3635 |
DOI: |
10.1038/s41392-024-01753-z |
Popis: |
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection disrupts the epithelial barrier and triggers airway inflammation. The envelope (E) protein, a core virulence structural component of coronaviruses, may play a role in this process. Pathogens could interfere with transepithelial Cl− transport via impairment of the cystic fibrosis transmembrane conductance regulator (CFTR), which modulates nuclear factor κB (NF-κB) signaling. However, the pathological effects of SARS-CoV-2 E protein on airway epithelial barrier function, Cl− transport and the robust inflammatory response remain to be elucidated. Here, we have demonstrated that E protein down-regulated the expression of tight junctional proteins, leading to the disruption of the airway epithelial barrier. In addition, E protein triggered the activation of Toll-like receptor (TLR) 2/4 and downstream c-Jun N-terminal kinase (JNK) signaling, resulting in an increased intracellular Cl− concentration ([Cl−]i) via up-regulating phosphodiesterase 4D (PDE4D) expression in airway epithelial cells. This elevated [Cl−]i contributed to the heightened airway inflammation through promoting the phosphorylation of serum/glucocorticoid regulated kinase 1 (SGK1). Moreover, blockade of SGK1 or PDE4 alleviated the robust inflammatory response induced by E protein. Overall, these findings provide novel insights into the pathogenic role of SARS-CoV-2 E protein in airway epithelial damage and the ongoing airway inflammation during SARS-CoV-2 infection. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|